Company Overview

Update
Founded:
2001
Founders:
Howard Salwen
Headquarters:
Waltham, MA
Funding:
$81.50M
Categories:
Biotechnology

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

Description

Update

Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.

The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.

Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures.

The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

Current Team (1)

Update

Board Members and Advisors (2)

Update

Funding Rounds (4) - $81.50M

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Proteon Therapeutics

    200 West Street

    Waltham, MA 02451

    USA

Images (1)

Update
  • D720e9acdf0e0f344cfb92af083be113